The Pharmaceutical Journal
Vol 274 No 7344 p412
9 April 2005

This article
Reprint   Photocopy

  Acrobat Reader

News summary

MeReC updates HRT advice

Evidence points to an overall net harm for use of hormone replacement therapy in chronic disease prevention, MeReC Bulletin advises. The latest issue of the bulletin (PDF 2MB) concludes that risks associated with HRT use should be communicated clearly. It also points out that the risk-benefit profile for individual women will change over time, making regular review necessary. The bulletin concludes that short-term use of HRT is effective for relief of menopausal symptoms.